Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Urologic Neoplasms × Glycopyrrolate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urologic Neoplasms 1 Urinary Bladder Neoplasms 1 Neurofibromatoses 1 Neoplasms 1 Hydrocephalus 1 Headache 1 Epilepsy 1 Abdominal Neoplasms 1

Interventions

Sugammadex 2 Neostigmine 2 zidovudine 5'-monophosphate-mannose-albumin conjugate 1 galactosamine-conjugated serum albumin-conjugated-(rhodamine X)20 1 Surveys and Questionnaires 1 Rocuronium 1 Ringer's acetate 1 Glycopyrrolate 1 Albumins 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03138967 2020-09-22

Investigation of Sugammadex in Outpatient Urological Procedures

M.D. Anderson Cancer Center

Phase 4 Completed

54 enrolled 12 charts

Urinary Bladder Neoplasms, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡